Instructions for Eucabal syrup bottle 100 ml
Composition
active ingredients: 100 g of syrup contain: liquid extract of plantain (Extractum Plantaginis liquidum) (1:2-2.5) 3 g, liquid extract of thyme (Extractum Thymi liquidum) (1:2-2.5) 15 g;
excipients: methyl parahydroxybenzoate (E 218), propyl parahydroxybenzoate (E 216), invert sugar syrup (glucose monohydrate, fructose, sucrose, purified water).
Dosage form
Syrup.
Main physical and chemical properties: Dark brown liquid from clear to cloudy.
Pharmacotherapeutic group
Medicines used for coughs and colds. ATX code R05C A10.
Pharmacological properties
Pharmacodynamics.
Substances contained in liquid extracts of both plantain and thyme, in particular essential oils, as expectorants affect the properties, formation, and transportation of bronchial secretions.
There is both an indirect reflex effect through the gastric mucosa and a direct effect of essential oils on the bronchial glands, which enhances their activity. This contributes to the increase, dilution and dissolution of bronchial secretions, as well as increased transport of secretions through the ciliated epithelium. This is especially important in the later stages of acute bronchitis and chronic bronchitis, when there is increased secretion of viscous mucus by the submucosal glands. In addition, essential oils, due to their surface activity, reduce the binding capacity of highly viscous mucus on the tracheobronchial mucosa.
Thyme is characterized by the pronounced antimicrobial potential of thymol and carvacrol. Plant mucilages of plantain help protect damaged bronchial mucosa from further irritation.
Pharmacokinetics.
Not studied.
Indication
Symptomatic treatment of inflammatory diseases of the respiratory tract. Expectorant for the symptomatic treatment of productive cough. Supportive agent for whooping cough.
Contraindication
Hypersensitivity to the components of the drug, fructose intolerance; hypersensitivity to alkyl-4-hydroxybenzoates. Hypersensitivity to plants of the Lamiaceae family, celery and birch pollen (cross-reaction is possible).
Gastroesophageal reflux disease, including reflux esophagitis, gastritis with increased acidity of gastric juice, gastric and duodenal ulcers, severe liver or kidney disease.
Special safety precautions
Before use, the syrup in the bottle must be shaken. The presence of plant components in the preparation may cause the syrup to become cloudy, but this does not reduce the therapeutic effectiveness of the drug.
The drug Evkabal® syrup contains 6.5 vol. % ethanol, which poses a risk for patients with epilepsy, chronic alcoholism, liver disease, and organic brain diseases.
Do not use in patients with fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltose malabsorption. Due to the sugar content, it may be harmful to teeth (caries).
At the first signs of reactions caused by hypersensitivity, the drug should not be continued.
Use with caution in patients with diabetes.
Instructions for diabetic patients
Evkabal® syrup contains glucose, fructose and sucrose with a total sugar content in terms of sucrose of 0.6 g/ml. Thus, 1 teaspoon (5 ml) contains 3 g of sucrose or 0.25 bread units, and 1 dessert spoon (10 ml) contains 6 g of sucrose or 0.5 bread units.
Interaction with other medicinal products and other types of interactions
Do not use simultaneously with antitussives and drugs that reduce sputum secretion. Due to the ethanol content (6.5% vol.), there is a possibility of worsening or enhancing the effect of other drugs.
Application features
If symptoms worsen during treatment with the drug and/or shortness of breath, fever, purulent sputum appear, you should consult a doctor.
If symptoms persist for a week, you should consult a doctor.
Use during pregnancy or breastfeeding
Due to the lack of sufficient data, it is not recommended to use the drug during these periods.
The ability to influence the reaction speed when driving or working with other mechanisms
It has no effect when used in recommended doses, but it should be noted that the excipients include ethanol 6.5% vol.
Method of administration and doses
Children aged 1 to 5 years should be given 1 teaspoon (5 ml) 3-5 times a day. Children aged 6 to 12 years - 1 dessert spoon (10 ml) 3-5 times a day. Children aged 12 years and older and adults should be given 1-2 dessert spoons (10-20 ml) 3-5 times a day.
The duration of treatment is determined by the doctor individually, depending on the course of the disease and the patient's condition.
Children
Do not prescribe to children under 1 year of age.
Overdose
Symptoms: Overdose may cause nausea, accompanied by coughing.
Treatment. Drug withdrawal. Symptomatic therapy.
Side effects
Gastrointestinal disorders (including nausea, vomiting, diarrhea), hypersensitivity reactions, including skin rashes, urticaria, itching, angioedema, shortness of breath, exanthema are possible.
Expiration date
2 years.
Do not use the product after the expiry date stated on the packaging. After opening the bottle, the product is suitable for use for 12 weeks.
Storage conditions
Store out of the reach of children at a temperature not exceeding 25 °C.
Packaging
100 ml of syrup in a glass bottle. 1 bottle in a cardboard box.
Vacation category
Without a prescription.
Producer
Pharma Wernigerode GmbH.
Location of the manufacturer and address of its place of business.
Dornbergsweg 35, 38855 Wernigerode, Germany.
Applicant
Esparma GmbH, Germany
Location of the applicant.
Bielefelder Strasse 1, 39171 Sulzetal, Germany.
